113 related articles for article (PubMed ID: 8168695)
1. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations.
Valera A; Fillat C; Costa C; Sabater J; Visa J; Pujol A; Bosch F
FASEB J; 1994 Apr; 8(6):440-7. PubMed ID: 8168695
[TBL] [Abstract][Full Text] [Related]
2. Correction of diabetic alterations by glucokinase.
Ferre T; Pujol A; Riu E; Bosch F; Valera A
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7225-30. PubMed ID: 8692973
[TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene.
Valera A; Rodriguez-Gil JE; Yun JS; McGrane MM; Hanson RW; Bosch F
FASEB J; 1993 Jun; 7(9):791-800. PubMed ID: 8330686
[TBL] [Abstract][Full Text] [Related]
4. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver.
Riu E; Bosch F; Valera A
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2198-202. PubMed ID: 8700908
[TBL] [Abstract][Full Text] [Related]
5. Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.
Riu E; Mas A; Ferre T; Pujol A; Gros L; Otaegui P; Montoliu L; Bosch F
Diabetes; 2002 Mar; 51(3):704-11. PubMed ID: 11872670
[TBL] [Abstract][Full Text] [Related]
6. Evidence from transgenic mice that myc regulates hepatic glycolysis.
Valera A; Pujol A; Gregori X; Riu E; Visa J; Bosch F
FASEB J; 1995 Aug; 9(11):1067-78. PubMed ID: 7649406
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.
Valera A; Pujol A; Pelegrin M; Bosch F
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9151-4. PubMed ID: 8090784
[TBL] [Abstract][Full Text] [Related]
8. Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.
Valera A; Rodriguez-Gil JE; Bosch F
J Clin Invest; 1993 Jul; 92(1):4-11. PubMed ID: 8100835
[TBL] [Abstract][Full Text] [Related]
9. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver.
Ferre T; Riu E; Bosch F; Valera A
FASEB J; 1996 Aug; 10(10):1213-8. PubMed ID: 8751724
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of calcium phosphate enhances recombinant adeno-associated virus-mediated gene therapy in diabetic mice.
Yang YW; Chao CK
J Gene Med; 2003 May; 5(5):417-24. PubMed ID: 12731090
[TBL] [Abstract][Full Text] [Related]
11. Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia.
Otaegui PJ; Ferre T; Pujol A; Riu E; Jimenez R; Bosch F
Hum Gene Ther; 2000 Jul; 11(11):1543-52. PubMed ID: 10945768
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism.
Barberà A; Rodríguez-Gil JE; Guinovart JJ
J Biol Chem; 1994 Aug; 269(31):20047-53. PubMed ID: 8051090
[TBL] [Abstract][Full Text] [Related]
13. Long-term glycemic control with hepatic insulin gene therapy in streptozotocin-diabetic mice.
Thulé PM; Campbell AG; Jia D; Lin Y; You S; Paveglio S; Olson DE; Kozlowski M
J Gene Med; 2015; 17(8-9):141-52. PubMed ID: 26190010
[TBL] [Abstract][Full Text] [Related]
14. High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic mice.
Lim IK; Dumenco LL; Yun J; Donovan C; Warman B; Gorodetzkaya N; Wagner TE; Clapp DW; Hanson RW; Gerson SL
Cancer Res; 1990 Mar; 50(6):1701-8. PubMed ID: 2407342
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.
Veerababu G; Tang J; Hoffman RT; Daniels MC; Hebert LF; Crook ED; Cooksey RC; McClain DA
Diabetes; 2000 Dec; 49(12):2070-8. PubMed ID: 11118009
[TBL] [Abstract][Full Text] [Related]
16. The concentration of P-enolpyruvate carboxykinase protein in murine tissues in diabetes of chemical and genetic origin.
Veneziale CM; Donofrio JC; Nishimura H
J Biol Chem; 1983 Dec; 258(23):14257-62. PubMed ID: 6643479
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
Li YG; Ji DF; Zhong S; Lin TB; Lv ZQ
Chem Biol Interact; 2015 Jan; 225():70-9. PubMed ID: 25446853
[TBL] [Abstract][Full Text] [Related]
18. Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi.
Gómez-Valadés AG; Vidal-Alabró A; Molas M; Boada J; Bermúdez J; Bartrons R; Perales JC
Mol Ther; 2006 Feb; 13(2):401-10. PubMed ID: 16271515
[TBL] [Abstract][Full Text] [Related]
19. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
Mas A; Montané J; Anguela XM; Muñoz S; Douar AM; Riu E; Otaegui P; Bosch F
Diabetes; 2006 Jun; 55(6):1546-53. PubMed ID: 16731816
[TBL] [Abstract][Full Text] [Related]
20. Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene.
Xu J; Lu Y; Ding F; Zhan X; Zhu M; Wang Z
World J Surg; 2007 Sep; 31(9):1872-1882. PubMed ID: 17653584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
